Clinical Trial Update: Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the antibody response and safety of a Group B Streptococcus trivalent vaccine in HIV-positive and HIV-negative pregnant women and their…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection

Drugs mentioned

• GBS Trivalent Vaccine (Group B Streptococcus vaccine (trivalent))

Snippet

Sponsor: Novartis Vaccines | Conditions: Streptococcal Infections, Gram-Positive Bacterial Infections | Phase 2 | Status: COMPLETED | Results posted: 2014-09-12